At a glance
- Originator Fujisawa
- Class Small molecules
- Mechanism of Action Aldehyde reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetic neuropathies
Most Recent Events
- 07 May 2003 Discontinued - Preclinical for Diabetic neuropathies in Japan (unspecified route)
- 30 May 2001 Profile reviewed but no significant changes made
- 23 Jun 1998 Commercial data has been reviewed by Fujisawa